CEACAM1 as a central modulator of metabollsrn, tumor progression, anglogenesls and Immunlty;CEACAM1 : Modulateur central du métabolisme, de la progression tumorale, de I'angiogenèse et de I'immunité

Medecine/Sciences

Volumn 25, Issue 3, 2009, Pages 247-252

  Nouvion, Anne Laure ^a   Beauchemin, Nicole ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN; PROTEIN KINASE ZAP 70; SERINE; WNT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIUM ADHERENCE; CANCER INHIBITION; CELL ADHESION; CELL INCLUSION; DNA MODIFICATION; EPITHELIUM CELL; GENE; HEMATOPOIETIC CELL; HEPATITIS VIRUS; LIPID METABOLISM; NONHUMAN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR VASCULARIZATION;

BACTERIA (MICROORGANISMS); MURINE HEPATITIS VIRUS;

EID: 64649107448     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2009253247     Document Type: Article

References (30)

1. Beauchemin N, Draber P, Dveksler G, et at. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999 ; 252 : 243-9.
2. Gray-Owen SD, Blumberg RS. CEACAM1: contact-dependent control of immunity. Nat Rev Immunol 2006; 6:433-46.
3. Létourneau S, Beauchemin N. Rôles des antigènes carcino-embryonnaires dans la cancénsation et la progression tumorale. Med Sci (Paris) 1997;13 : 483-91.
4. ~/~ mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59. J Virol 2004 ; 78 : 10156-65.
5. Najjar SM. Regulation of insulin action by CEACAM1. Trends Endocrinol Metab 2002 ; 13 : 240-5.
6. Poy MN, yang y, Rezaei K, et al. CEACAM1 regulates insulin clearance in liver. Nat Genet 2002 ; 30: 270-6.
7. Xu 6. Targeted disruption of Ceacaml promotes diet-induced hepatic steatosis and insulin resistance. Endocrinology 2009 (sous presse).
8. Formisano P, Najjar SM, Gross CN, et at. Receptor-mediated internalization of insulin. Potential role of ppl20/HA4, a substrate of the insulin receptor kinase. J Biot Chem 1995; 270 : 24073-7.
9. Horst A, Wagener C. CEA-related CAMs. Hum Exp Pharmacol 2004 ; 165 : 283-341.
10. Simeone DM, Ji B, Banerjee M, et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 2007; 34: 436-43.
11. Kunath T, Ordoñez-Garcia C, Turbide C, Beauchemin N. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene 1995; 11 : 2375-82.
12. Phan D, Cheng CJ, Galfione M, et at. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res 2004 ; 64: 3072-8.
13. Beauchemin N, Kunath T, Robitaille J, et at. Association of biliary gjycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene 1997 ; 14 : 783-90.
14. Izzi L, Turbide C, Houde C, Kunath T, Beauchemin N. Cis-determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 1999 ; 18 : 5563-72.
15. ~/~ mice. Oncogene 2009 ; 27 : 4943-53.
16. Leung N, Turbide C, Olson M, et ai. Deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (Ceacaml) gene contributes to colon tumor progression in a murine model of carcinogenesis. Oncogene 2006; 25: 5527-36.
17. Liu W, Wei W, Winer D, et at. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene 2007 ; 26 : 2747-58.
18. Obrmk B. On the role of CEACAM1 in cancer. Lung Cancer 2008 ; 60: 309-12.
19. Ebrahimnejad A, Streichert T, Nollau P, et at. CEACAMl enhances invasion and migration of melanocytic and melanoma ceils. Am J Pathol 2004 ; 165 : 1781-7.
20. Ergiin S, Kilik N, Ziegeler G, et at. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Moi Cell 2000 ; 5 : 311-20.
21. Horst AK, Ito WD, Dabelstein J, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest 2006; 116: 1596-605.
22. Kilic N, Oliveira-Ferrer L, Wurmbach JH, et at. Pro-angiogenic signaling by the endothelial presence of CEACAM1. J Biot Chem 2005 ; 28 : 2361-9.
23. Muller MM, Singer BB, Klaile E, et at. Transmembrane CEACAM1 affects integrindependent signaling and regulates extracellular matrix protein-specific morphology and migration of endothelial cells. Blood 2005 ; 105 : 3925-34.
24. Tilki D, Irmak S, Oliveira-Ferrer L, et al. CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene 2006 ; 25: 4965-74.
25. Oliveira-Ferrer L, Tilki D, Ziegeler G, et al. Dual role of carcinoembryonic antigen-reiated cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer. Cancer Res 2004 ; 64 : 8932-8.
26. Kilic N, Oliveira-Ferrer L, Neshat-Vahid S, et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Proxl. Blood 2007 ; 110: 4223-33.
27. Nagaishi T, Pao L, Lin SH, et al. SHP1 phosphatase-dependent 1 cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 2006; 25: 769-81.
28. Donda A, Mori L, Shamshiev A, et al. Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response. Eur J Immunol 2000 ; 30: 2593-603.
29. Chen Z, Chen L, Qiao SW, et at. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signalling by targeting ZAP-70. J Immunol 2008; 180: 6085-93.
30. Markel G, Lieberman N, Katz G, et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol 2002 ; 168 : 2803-10.